Search…

CanSino Biologics (06185.HK): Inhaled tuberculosis vaccine obtains clinical trial approval in Indonesia.

16/05/2025

Zhixin Finance APP News, Kangxinuo Biotech (06185.HK) announced that the company has obtained approval for Phase I clinical trials from the Food and Drug Administration of Indonesia, and can proceed with the related clinical trials of the inhaled tuberculosis vaccine (type 5 adenovirus vector) developed by the company (inhaled tuberculosis vaccine).

Latest

1 m ago

Piper Sandler: Maintain rating on Myriad Genetics (MYGN.US) as a Hold, adjusted from Buy to Hold, target price adjusted from $12.50 to $9.00.

2 m ago

Jamie Dimon, CEO of JPMorgan Chase, sparked heated discussions earlier this year with his strong criticism of remote work. In an interview with Bloomberg TV on Thursday, he admitted that he was "a bit emotional" at the time but still stood by his stance of having employees return to the office to work. "I was indeed a bit emotional," Dimon said, referring to his remarks at an internal meeting in Ohio in February.

2 m ago

"I am indeed a bit emotional" - Damon responds to remote work controversy, reiterating that JPMorgan's position remains unchanged.

2 m ago

The mid-to-long term German bond yields fell by about 8 basis points, Germany expects the economic weakness to result in a decrease in tax revenue of 33.3 billion euros.

3 m ago

Piper Sandler: Maintains Illumina (ILMN.US) rating, adjusted from Hold to Buy rating, target price adjusted from $190.00 to $185.00.

See all latest